Loreta Garretson-Vaivilavicius, M.D.

Media Releases

Get to know Hematologist-Oncologist Dr. Loreta Garretson-Vaivilavicius, who serves patients in New Jersey.

A board-certified hematologist-oncologist, Dr. Garretson-Vaivilavicius is affiliated with AtlantiCare Cancer Care Institute - EHT. Additionally, she is a teaching physician to both medical students and residents, and will soon be an associate professor of medicine in Temple University through Fox Chase. Dr. Garretson-Vaivilavicius is also a NCI investigator for clinical trials, which are available through the cancer center with Fox Chase.

“I am successful when I match resources with patient needs. We focus on what we can do, not on what we cannot. I listen and engage them in conversation and they know we are working for them, behind the scenes. We celebrate every small victory to make life happier for each patient. This encourages me and my staff, every day” expressed the doctor.

More people are surviving cancer than ever before, and AtlantiCare Cancer Care Institute is proud to do their part in the South Jersey communities they serve. As a Fox Chase Cancer Center Partner, they offer the full spectrum of cancer care — from prevention and early detection to advanced treatment options and a full range of support services to see patients through. Their dedicated cancer care team is led by some of the region’s leading oncologists, known as much for their compassionate care as their skill in fighting cancer.

Academically, Dr. Garretson-Vaivilavicius' appreciation for modern medicine springs from years of going without. She grew up in Lithuania, through the early years of post-Soviet independence where medicine lagged behind. When her grandmother developed cancer, she could not get the level of care that had been standard in the United States for years. They had no estrogen and progesterone receptor testing and struggled to do simple things. That experience shaped her philosophy and her future, inspiring her towards lifting barriers to care. 

After completing her medical education from the Kaunas University of Medicine in 2003, a foreign exchange summer program brought her to Columbia University, and then to St. Michael’s Hospital Medical Center in Newark, where she did her residency in internal medicine. There, she also completed a fellowship in hematology/oncology in 2015 and was named Chief third year Fellow.

Subsequent to her education, the doctor attained board certification in hematology, medical oncology, and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Her drive then brought her to rural Kentucky, in tobacco country where cancer is a real problem. She built a hematology/oncology program at Murray Calloway County Hospital, which grew from no patients to over 3,000 inside two years. Before, area residents had to drive a long distance for cancer care and many did without.

In southern New Jersey, Dr. Garretson-Vaivilavicius finds the same level of challenge and satisfaction. In AtlantiCare, she found similar values and a philosophy very close to her heart, providing local care to communities in need.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, sickle-cell disease, and a rare hematologic related syndromes, and diseases.

Speaking multiple languages, Dr. Garretson-Vaivilavicius is fluent in English, Lithuanian, Polish, and Russian.

Recommended Articles

• Exercise Proven to Help Lymphoma Patients

  People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Woman Who Battled Lymphoma Three Times Starts Support Group

  Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• Boy Who Donated Hair to Kids with Cancer Fights Stage Four Lymphoma

  Torrin Breneman first learned about cancer three years ago, and it made an impact on him. When he learned what cancer can do to a person, and that it affects children across the world, Torrin made a decision to do something about it. He grew out his hair for the next three years, with the intentions...

• What Are Lymphocytes?

  A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...